The global local anesthesia drugs market size was $2,643.50 million in 2021 and is predicted to grow with a CAGR of 6.4%, by generating a revenue of $4,724.80 million by 2031.
The global market for local anesthetic medications is expanding as a result of an increase in surgeries, particularly those related to accidents and chronic illnesses like cancer, cardiovascular disease, and orthopedic disorders. Additionally, there are more injuries now that need medical attention. As per analysis, more than 5 million were hurt in collisions in North America and were seeking medical attention in 2020. These factors are projected to boost the local anesthesia market size during the forecast period.
Anesthesia is defined as a loss of feeling with or without loss of consciousness and can be effectively attained with a vast variety of medications with incredibly complex chemical structures. There are numerous central nervous system (CNS) depressants on the list of such substances, in addition to the traditional anesthetic agents like general and local anesthetics, as well as analgesics, sedative/hypnotics anticonvulsants, and skeletal muscle relaxants. Although each of these substances has a different mode of action, they all ultimately generate anesthetic effects by interfering with the conduction of sensory neurons and, occasionally, motor neurons. Today, several of these substances are frequently employed in clinical settings to speed up operations and other medical procedures. As a result, this will increase demand for the local anesthesia market.
In addition, the creation and approval of new local anesthetic medications is proving to be a new source of income for market participants. According to the United Nations Department of Economic and Social Affairs, one in four residents of Europe and North America maybe 65 years of age or older by 2050. Chronic illnesses like cardiovascular and neurological conditions are becoming more prevalent in older populations as a result of the growing geriatric population, which drives up the demand for local anesthesia medications.
However, the absence of healthcare facilities in undeveloped nations and distant regions, as well as the shortage of anesthesia doctors and certified anesthesia nurses per capita, are likely to hinder the expansion of the local anesthesia drugs market. Other branded drugs, lack of awareness among patients, and high costs of procedures may further restrain the expansion of this market over the predicted period.
Additionally, one or two patients out of every 1000 who receive general anesthesia during surgery may not be aware that they are partially awake. Although there is a very low likelihood that one might feel discomfort, it is possible. People who get sedative medications before surgery are unable to move, express their anguish, or alert the medical staff. It's possible that patients will experience long-term psychological issues as a result, akin to post-traumatic stress disorder. Unintentional intraoperative awareness is what this is, and it's one of the biggest issues facing the anesthesia market.
Surgical procedures are difficult and painful so as giving anesthesia, currently, research is going on to make local anesthetic application less painful. An injection of local anesthetic causes a burning sensation because it contains an acidic solution. Current research is examining the advantages of developing a more neutral solution to make the anesthetic injection procedure more pleasant. One formula under investigation involves adding sodium bicarbonate to the lidocaine and epinephrine solution. Theoretically, this neutral local anesthetic solution offers two benefits: a less painful injection and a quicker start to desensitization. It is impossible to emphasize the value of local anesthetics. Today's surgical and dental treatments would require more invasive techniques to make patients comfortable if local anesthetics were not used. The discipline of local anesthetics will continue to advance in the never-ending hunt for pain relief with sustained research and innovation.
The key players profiled in this report include Novartis AG, Aspen Pharmacare, Sagent Pharmaceuticals, Pacira Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi, Mylan N.V., GSK plc., AstraZeneca plc, and Hikma Pharmaceuticals plc.
The global market for local anesthetic medications is expanding as a result of an increase in surgeries, particularly those related to accidents and chronic illnesses like cancer, cardiovascular disease, and orthopedic disorders. Additionally, there are more injuries now that need medical attention. As per analysis, more than 5 million were hurt in collisions in North America and were seeking medical attention in 2020. These factors are projected to boost the local anesthesia market size during the forecast period.
Anesthesia is defined as a loss of feeling with or without loss of consciousness and can be effectively attained with a vast variety of medications with incredibly complex chemical structures. There are numerous central nervous system (CNS) depressants on the list of such substances, in addition to the traditional anesthetic agents like general and local anesthetics, as well as analgesics, sedative/hypnotics anticonvulsants, and skeletal muscle relaxants. Although each of these substances has a different mode of action, they all ultimately generate anesthetic effects by interfering with the conduction of sensory neurons and, occasionally, motor neurons. Today, several of these substances are frequently employed in clinical settings to speed up operations and other medical procedures. As a result, this will increase demand for the local anesthesia market.
In addition, the creation and approval of new local anesthetic medications is proving to be a new source of income for market participants. According to the United Nations Department of Economic and Social Affairs, one in four residents of Europe and North America maybe 65 years of age or older by 2050. Chronic illnesses like cardiovascular and neurological conditions are becoming more prevalent in older populations as a result of the growing geriatric population, which drives up the demand for local anesthesia medications.
However, the absence of healthcare facilities in undeveloped nations and distant regions, as well as the shortage of anesthesia doctors and certified anesthesia nurses per capita, are likely to hinder the expansion of the local anesthesia drugs market. Other branded drugs, lack of awareness among patients, and high costs of procedures may further restrain the expansion of this market over the predicted period.
Additionally, one or two patients out of every 1000 who receive general anesthesia during surgery may not be aware that they are partially awake. Although there is a very low likelihood that one might feel discomfort, it is possible. People who get sedative medications before surgery are unable to move, express their anguish, or alert the medical staff. It's possible that patients will experience long-term psychological issues as a result, akin to post-traumatic stress disorder. Unintentional intraoperative awareness is what this is, and it's one of the biggest issues facing the anesthesia market.
Surgical procedures are difficult and painful so as giving anesthesia, currently, research is going on to make local anesthetic application less painful. An injection of local anesthetic causes a burning sensation because it contains an acidic solution. Current research is examining the advantages of developing a more neutral solution to make the anesthetic injection procedure more pleasant. One formula under investigation involves adding sodium bicarbonate to the lidocaine and epinephrine solution. Theoretically, this neutral local anesthetic solution offers two benefits: a less painful injection and a quicker start to desensitization. It is impossible to emphasize the value of local anesthetics. Today's surgical and dental treatments would require more invasive techniques to make patients comfortable if local anesthetics were not used. The discipline of local anesthetics will continue to advance in the never-ending hunt for pain relief with sustained research and innovation.
The key players profiled in this report include Novartis AG, Aspen Pharmacare, Sagent Pharmaceuticals, Pacira Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi, Mylan N.V., GSK plc., AstraZeneca plc, and Hikma Pharmaceuticals plc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the local anesthesia drugs market analysis from 2021 to 2031 to identify the prevailing local anesthesia drugs market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the local anesthesia drugs market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global local anesthesia drugs market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Drugs Type
- Bupivacaine
- Ropivacaine
- Lidocaine
- Chloroprocaine
- Prilocaine
- Benzocaine
- Other local anesthetics
By Application
- Injectable
- Surface Anesthetic
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- United Arab Emirates
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Fresenius Kabi AG
- Novartis AG
- Aspen Holdings
- Sagent Pharmaceuticals
- Pacira Pharmaceuticals, Inc.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Septodont Healthcare India Pvt. Ltd.
- Baxter International Inc.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE
CHAPTER 5: LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION
CHAPTER 6: LOCAL ANESTHESIA DRUGS MARKET, BY REGION
CHAPTER 7: COMPETITIVE LANDSCAPE
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report titled, “Local Anesthesia Drugs Market," the local anesthesia drugs market was valued at $2.6 billion in 2021, and is estimated to reach $4.7 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031.Local anesthesia drugs inhibit the excitation of nerves endings by blocking the conduction in peripheral nerves owing to which they help in reducing pain sensation. Local anesthesia drugs help in preventing the pain caused by certain medical procedures such as biopsy, cancer-related pain, open sores, rashes, and ivy contact. Also, these drugs are used during labor pain where the doctor may provide epidural anesthesia. With local anesthesia drugs only the body part is numb while the patient is still conscious and alert. Local anesthesia drugs are safer than general anesthesia drugs and opioids. Local anesthesia drugs are also used during dental procedures such as tooth extraction.
Healthcare professionals consider several factors while deciding whether to use local anesthesia drugs or general anesthesia drugs. For instance, if the medical procedure is minor like stitching the wound then local anesthesia drugs can be used. When there is no need for patient to become unconscious or when there is no need to relax muscles, local anesthesia drugs can be used. Also, when the procedure is quick and does not need to stay overnight, these drugs can be used. Furthermore, several factors are considered for deciding which dose of anesthesia should be given based on person’s age, medical conditions, weight, allergies, aim of procedure, and others.
Local anesthesia drugs offer several advantages that relieves pain without major side-effects. Local anesthesia can be used in three different ways. This includes local anesthesia drugs via local application, nerve blocks, and local injection. The local application means local anesthetic ointment is applied to mouth ulcers or open sores to reduce the pain or for minor operations. In local injection, the anesthetic drug is injected under the skin. In such injections, one does not feel needle pricks as doctor sews a wound. The local anesthesia drugs wear off quickly and to prolong the effect of local anesthesia other drugs like clonidine, steroids, and epinephrine are used. Local anesthesia offers relief from pain including labor pain, joint pain, and others. Some of the popular over the counter (OTC) topical anesthetics help in managing pain related to minor burns, sore throat, tooth, gum, bug bites, hemorrhoids, and others. These factors are anticipated to boost the local anesthesia drug market share during the forecast period.
Local anesthesia drugs can cause soreness, tingling feeling, headache, blood pressure, and others which is estimated to restrict the market growth. In some cases, these drugs can also result in allergic reaction that can cause itching, hives, and breathing difficulties.
The growing popularity of local anesthesia drugs and its use in carpal tunnel release, discectomy, breast lumpectomy, and stool removal is anticipated to generate excellent opportunities in the market. Local anesthesia is very safe compared to general anesthesia. Also, the local anesthesia in topical treatment can be used for anything involving a needle poke, applying or removing stitches, endoscopy, cataract surgery, IV insertion, laser treatments, and others. The injectable local anesthetics are widely used for pain management especially during pacemaker insertion, root canal, deep wart removal, bone marrow biopsy, lumbar puncture, and others. These factors will drive excellent opportunities in the local anesthesia drugs market.
The local anesthesia drugs market is segmented on the basis of drugs type, application, and region. On the basis of drug type, the market is classified into bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and other local anesthetics. As per application, it is divided into injectable, and surface anesthetic. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, UAE, South Africa, and rest of LAMEA).
The key players profiled in the study include Novartis AG, Aspen Pharmacare, Sagent Pharmaceuticals, Pacira Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi, Mylan N.V., GSK plc., AstraZeneca plc, and Hikma Pharmaceuticals plc. The major players in the market have been actively engaged in the adoption of various strategies such as acquisition, product launch, and expansion to remain competitive and gain an advantage over the competitors in the market. For instance, in January 2020, Novartis, the leading pharmaceutical company, has completed the acquisition of The Medicines Company.
Key Market Insights
- By drugs type, the lidocaine segment was the highest revenue contributor to the market in 2021 and bupivacaine is estimated to be the fastest growing during the forecast period.
- As per application, the injectable segment was the highest revenue contributor to the market in 2021 and surface anesthetic is projected to be the fastest growing segment during the forecast period.
- Based on region, North America was the highest revenue contributor in the market, accounting for $1,099.7 million in 2021 and is anticipated to generate a CAGR of 5.9% during the forecast period.
Companies Mentioned
- Fresenius Kabi AG
- Novartis AG
- Aspen Holdings
- Sagent Pharmaceuticals
- Pacira Pharmaceuticals, Inc.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Septodont Healthcare India Pvt. Ltd.
- Baxter International Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Related Reports
Local Anesthesia Drugs - Global Strategic Business Report
- Report
- 94 Pages
- Global
From
Local Anesthesia Drugs Global Market Report 2024
- Report
- 200 Pages
- Global
From
From
From
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
